198 related articles for article (PubMed ID: 34568327)
1. Dexmedetomidine Relieves Neuropathic Pain in Rats With Chronic Constriction Injury via the Keap1-Nrf2 Pathway.
Liu Y; Liu W; Wang XQ; Wan ZH; Liu YQ; Zhang MJ
Front Cell Dev Biol; 2021; 9():714996. PubMed ID: 34568327
[TBL] [Abstract][Full Text] [Related]
2. MG53 ameliorates nerve injury induced neuropathic pain through the regulation of Nrf2/HO-1 signaling in rats.
Zhu XZ; Wang JQ; Wu YH
Behav Brain Res; 2023 Jul; 449():114489. PubMed ID: 37169128
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine alleviates inflammation in neuropathic pain by suppressing NLRP3 via Nrf2 activation.
Shan W; Liao X; Tang Y; Liu J
Exp Ther Med; 2021 Oct; 22(4):1046. PubMed ID: 34434260
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 mediates the antinociceptive activity of dexmedetomidine in an acute inflammatory visceral pain rat model by activating the NF-κB sensor.
Lan J; Zheng J; Feng J; Peng W
Cell Biochem Funct; 2020 Jan; 38(1):97-105. PubMed ID: 31773760
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FTX ameliorates neuropathic pain by targeting miR-320a in a rat model of chronic constriction injury.
Lu Z; Zhang Y; Li Y
Folia Neuropathol; 2023; 61(3):291-300. PubMed ID: 37818689
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-340-5p relieved chronic constriction injury-induced neuropathic pain by targeting Rap1A in rat model.
Gao L; Pu X; Huang Y; Huang J
Genes Genomics; 2019 Jun; 41(6):713-721. PubMed ID: 30848438
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microRNA-19a-3p alleviates the neuropathic pain (NP) in rats after chronic constriction injury (CCI) via targeting KLF7.
Wang X; Pang J; Cui J; Liu A; Wang H
Transpl Immunol; 2023 Feb; 76():101735. PubMed ID: 36334791
[TBL] [Abstract][Full Text] [Related]
8. Nrf2/HO-1 signaling pathway participated in the protection of hydrogen sulfide on neuropathic pain in rats.
Chen H; Xie K; Chen Y; Wang Y; Wang Y; Lian N; Zhang K; Yu Y
Int Immunopharmacol; 2019 Oct; 75():105746. PubMed ID: 31325725
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effect of dexmedetomidine in rats after chronic constriction injury by mediating microRNA-101 expression and the E2F2-TLR4-NF-κB axis.
Zhang W; Yu T; Cui X; Yu H; Li X
Exp Physiol; 2020 Sep; 105(9):1588-1597. PubMed ID: 32706450
[TBL] [Abstract][Full Text] [Related]
10. PPAR γ Prevents Neuropathic Pain by Down-Regulating CX3CR1 and Attenuating M1 Activation of Microglia in the Spinal Cord of Rats Using a Sciatic Chronic Constriction Injury Model.
Li X; Guo Q; Ye Z; Wang E; Zou W; Sun Z; He Z; Zhong T; Weng Y; Pan Y
Front Neurosci; 2021; 15():620525. PubMed ID: 33841075
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal injection of dexmedetomidine ameliorates chronic neuropathic pain via the modulation of MPK3/ERK1/2 in a mouse model of chronic neuropathic pain.
Qian Y; Wang Q; Jiao J; Wang G; Gu Z; Huang D; Wang Z
Neurol Res; 2019 Dec; 41(12):1059-1068. PubMed ID: 31584354
[No Abstract] [Full Text] [Related]
12. Dexmedetomidine Alleviates CCI-Induced Neuropathic Pain via Inhibiting HMGB1-Mediated Astrocyte Activation and the TLR4/NF-κB Signaling Pathway in Rats.
Zhao E; Bai L; Li S; Li L; Dou Z; Huang Y; Li Y; Lv Y
Neurotox Res; 2020 Oct; 38(3):723-732. PubMed ID: 32607919
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-212-3p Attenuates Neuropathic Pain via Targeting Sodium Voltage-gated Channel Alpha Subunit 3 (NaV 1.3).
Li Y; Zhang X; Fu Z; Zhou Q
Curr Neurovasc Res; 2019; 16(5):465-472. PubMed ID: 31713483
[TBL] [Abstract][Full Text] [Related]
14. miR-101 down-regulates mTOR expression and attenuates neuropathic pain in chronic constriction injury rat models.
Xie T; Zhang J; Kang Z; Liu F; Lin Z
Neurosci Res; 2020 Sep; 158():30-36. PubMed ID: 31526851
[TBL] [Abstract][Full Text] [Related]
15. Silencing of secreted phosphoprotein 1 attenuates sciatic nerve injury-induced neuropathic pain: Regulating extracellular signal-regulated kinase and neuroinflammatory signaling pathways.
Xie H; Lu F; Li X; Wang E; Mo J; Liang W
Immun Inflamm Dis; 2024 Feb; 12(2):e1132. PubMed ID: 38415922
[TBL] [Abstract][Full Text] [Related]
16. miR-384-5p ameliorates neuropathic pain by targeting SCN3A in a rat model of chronic constriction injury.
Ye G; Zhang Y; Zhao J; Chen Y; Kong L; Sheng C; Yuan L
Neurol Res; 2020 Apr; 42(4):299-307. PubMed ID: 32098588
[No Abstract] [Full Text] [Related]
17. Downregulation of long noncoding RNA DLEU1 attenuates hypersensitivity in chronic constriction injury-induced neuropathic pain in rats by targeting miR-133a-3p/SRPK1 axis.
Li Z; Li A; Yan L; Yang T; Xu W; Fan P
Mol Med; 2020 Nov; 26(1):104. PubMed ID: 33167866
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine alleviates neuropathic pain by regulating JAK/STAT pathway in rats.
Xun S; Zheng R
J Cell Biochem; 2020 Mar; 121(3):2277-2283. PubMed ID: 31674072
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine relieves neuropathic pain by inhibiting hyperpolarization-activated cyclic nucleotide-gated currents in dorsal root ganglia neurons.
Yang Y; Xia Z; Meng Q; Liu K; Xiao Y; Shi L
Neuroreport; 2018 Aug; 29(12):1001-1006. PubMed ID: 29912028
[TBL] [Abstract][Full Text] [Related]
20. MC4R Is Involved in Neuropathic Pain by Regulating JNK Signaling Pathway After Chronic Constriction Injury.
Zhao Y; Xin Y; Chu H
Front Neurosci; 2019; 13():919. PubMed ID: 31551683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
